LXFR vs NBIX · P/E 16, rev $181.4M vs P/E 45, rev $1.77B
Luxfer Holdings PLC (LXFR) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
Luxfer Holdings PLC (LXFR) is a specialty industrial machinery company listed on US.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported LXFR revenue for 2026-06-28 was $181.4M. Net income was $8.4M. LXFR currently screens at market cap $345.4M and trailing P/E 16.3.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
LXFR currently screens at market cap $345.4M and trailing P/E 16.3. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the LXFR and NBIX stock pages for the full models.
Not investment advice.